Urinary Proteomics for Prediction of Preeclampsia
Authors:
- Justyna SiwyJSJustyna Siwy
- Janet E BrennandJBJanet E Brennand
- Petra ZürbigPZPetra Zürbig
- William MullenWMWilliam Mullen
- Julia FrankeJFJulia Franke
- James W McCullochJMJames W McCulloch
- Claire T RobertsCRClaire T Roberts
- Robyn A NorthRNRobyn A North
- Lucy C ChappellLCLucy C Chappell
- Harald MischakHMHarald Mischak
- Lucilla PostonLPLucilla Poston
- 1 March 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 57 (3) , 561-569
Abstract
Preeclampsia is a major determinant of fetal and maternal morbidity and mortality. We used a proteomic strategy to identify urinary biomarkers that predict preeclampsia before the onset of disease. We prospectively collected urine samples from women throughout pregnancy. Samples from gestational weeks 12 to 16 (n=45), 20 (n=50), and 28 (n=18) from women who subsequently had preeclampsia develop were matched to controls (n=86, n=49, and n=17, respectively). We performed capillary electrophoresis online coupled to micro-time-of-flight mass spectrometry. Disease-specific peptide patterns were generated using support vector machine-based software. Candidate biomarkers were sequenced by liquid chromatography-tandem mass spectrometry. From comparison with nonpregnant controls, we defined a panel of 284 pregnancy-specific proteomic biomarkers. Subsequently, we developed a model of 50 biomarkers from specimens obtained at week 28 that was associated with future preeclampsia (classification factor in cases, 1.032±0.411 vs controls, −1.038±0.432; P P P =0.043). Among the biomarkers are fibrinogen alpha chain, collagen alpha chain, and uromodulin fragments. The markers appear to predict preeclampsia at gestational week 28 with good confidence but not reliably at earlier time points (weeks 12–16 and 20). After prospective validation in other cohorts, these markers may contribute to better prediction, monitoring, and accurate diagnosis of preeclampsia.Keywords
This publication has 38 references indexed in Scilit:
- Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early PregnancyObstetrics & Gynecology, 2010
- Technical, bioinformatical and statistical aspects of liquid chromatography–mass spectrometry (LC–MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: A critical assessment☆Journal of Chromatography B, 2009
- Evaluation of Urine Proteome Pattern Analysis for Its Potential To Reflect Coronary Artery Atherosclerosis in Symptomatic PatientsJournal of Proteome Research, 2008
- Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2008
- Urinary Proteomics in Diabetes and CKDJournal of the American Society of Nephrology, 2008
- Urinary Proteomic Biomarkers in Coronary Artery DiseaseMolecular & Cellular Proteomics, 2008
- Capillary electrophoresis–mass spectrometry as a powerful tool in clinical diagnosis and biomarker discoveryMass Spectrometry Reviews, 2005
- Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studiesBMJ, 2005
- Urinary Placental Growth Factor and Risk of PreeclampsiaJAMA, 2005
- World Health Organization Systematic Review of Screening Tests for PreeclampsiaObstetrics & Gynecology, 2004